US$ 19.99
bpc-157 uses for injury recovery athletes and treatment: Science, safety, and legal concerns peptide bpc-157 BPC-157: Top Peptide
Description
BPC-157 has never undergone human clinical trials for any indication no phase 1 safety data, no pharmacokinetic studies, no efficacy trials

When people think a medicine is pricey, they frequently report benefits, even when its actually an inert substance

This can be fine or it can mean no emergency protocols, no physician oversight, and no accountability if something goes wrong
Zhuang H
